Table 5.
Protective effect of PCEB on lung γ-GT, GSR, and QR.
| Treatment | γ-GT (nM/min/mg protein) | GSR (nM/min/mg protein) | QR (nM/min/mg protein) |
|---|---|---|---|
| Control | 402.7 ± 10.3a | 233.7 ± 6.3b | 217.5 ± 4.0a |
| CCl4 1 mL/kg b.w. | 102.0 ± 5.5d | 191.7 ± 4.4e | 129.3 ± 2.0e |
| CCl4+Silymarin | 375.0 ± 5.6ab | 215.3 ± 2.3d | 204.5 ± 1.2b |
| CCl4+PCEB 200 mg/kg b.w. | 108.7 ± 6.4d | 176.3 ± 4.4f | 158.4 ± 4.3f |
| CCl4+PCEB 400 mg/kg b.w. | 124.6 ± 6.7d | 244.3 ± 2.2a | 197.2 ± 2.4d |
| PCEB 400 mg/kg b.w. | 325.0 ± 7.6c | 222.0 ± 3.2c | 200.4 ± 1.1c |
| Vehicle control | 361.0 ± 5.9bc | 210.9 ± 2.5d | 209.6 ± 2.3b |
Mean ± SD (n = 6). Means with different letters (a–e) indicate significance at P < 0.05.